Leukemia

Showing NaN - NaN of 213

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Acute Lymphoblastic Leukemia Trial in New York (gene-modified T cells targeted)

Active, not recruiting
  • Leukemia
  • Acute Lymphoblastic Leukemia
  • gene-modified T cells targeted
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Feb 1, 2023

Leukemia, Multiple Myeloma, Myelodysplastic Syndrome Trial in New York (biological, procedure, radiation, drug)

Active, not recruiting
  • Leukemia
  • +3 more
  • Palifermin
  • +6 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 23, 2023

Leukemia Trial in United States (mercaptopurine, methotrexate, tretinoin)

Completed
  • Leukemia
  • Scottsdale, Arizona
  • +209 more
Dec 14, 2022

Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma

Recruiting
  • Clinical Stage I Cutaneous Melanoma AJCC v8
  • +33 more
  • Informational Intervention
  • +4 more
  • Los Angeles, California
  • +4 more
Dec 14, 2022

Leukemia, Myelodysplastic Syndrome, Non-Hodgkins Lymphoma Trial in New York (fludarabine, cyclophosphamide, thiotepa, radiation

Completed
  • Leukemia
  • +4 more
  • fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 10, 2022

Leukemia Trial in Worldwide (Dasatinib)

Active, not recruiting
  • Leukemia
  • Birmingham, Alabama
  • +173 more
Dec 1, 2022

Selection of Allogeneic Hematopoietic Cell Donors Based on KIR

Active, not recruiting
  • Leukemia
  • KIR genotyping
  • HLA genotyping
  • Tampa, Florida
  • +9 more
Nov 29, 2022

Lymphoma, Leukemia Trial in United States (CPI-613)

Recruiting
  • Lymphoma
  • Leukemia
  • Duarte, California
  • +9 more
Nov 28, 2022

Chronic Myelomonocytic Leukemia, Leukemia Trial in United States (Ruxolitinib)

Active, not recruiting
  • Chronic Myelomonocytic Leukemia
  • Leukemia
  • Tampa, Florida
  • +4 more
Nov 11, 2022

Drug/Agent Toxicity by Tissue/Organ, Leukemia Trial in Canada, Puerto Rico, United States (asparaginase, cyclophosphamide,

Completed
  • Drug/Agent Toxicity by Tissue/Organ
  • Leukemia
  • Boston, Massachusetts
  • +9 more
Nov 9, 2022

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

Recruiting
  • Leukemia
  • +19 more
  • CYNK-001
  • Denver, Colorado
  • +9 more
Sep 9, 2022

Collecting and Storing Tissue From Young Patients With Cancer

Recruiting
  • Acute Lymphoblastic Leukemia
  • +13 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Birmingham, Alabama
  • +68 more
Aug 4, 2022

Leukemia, Myelodysplastic Syndrome, Lymphoma Trial in New York (CliniMACS Fractionation system (Arm A), CliniMACS Fractionation

Completed
  • Leukemia
  • +2 more
  • CliniMACS Fractionation system (Arm A)
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 12, 2022

Blood and Bone Marrow Samples in Chronic Myelogenous Leukemia

Active, not recruiting
  • Leukemia
  • DNA analysis
  • +3 more
  • San Diego, California
  • +160 more
Aug 2, 2022

Blood and Bone Marrow Samples From Previously Untreated Chronic

Completed
  • Leukemia
  • fluorescence in situ hybridization
  • +6 more
  • San Diego, California
  • +34 more
Aug 2, 2022

Bone Marrow and Blood Samples in Untreated Acute Myeloid

Completed
  • Leukemia
  • laboratory biomarker analysis
  • San Diego, California
  • +45 more
Aug 2, 2022

Tissue and Blood Samples From Acute Myeloid Leukemia

Active, not recruiting
  • Leukemia
  • DNA analysis
  • +7 more
  • Mountain View, California
  • +76 more
Aug 2, 2022

Hematopoietic and Lymphoid System Tumor, Leukemia, Lymphoma Trial in Canada, United States (procedure, biological, other)

Active, not recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +3 more
  • Birmingham, Alabama
  • +42 more
Jul 20, 2022

Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH

Recruiting
  • Chronic Graft-versus-Host-Disease
  • +4 more
    • San Francisco, California
    • +15 more
    Jun 17, 2022

    Solid Tumor, CNS Tumor, Lymphoma Trial in Canada, United States (Neratinib)

    Recruiting
    • Solid Tumor
    • +3 more
    • Phoenix, Arizona
    • +8 more
    Mar 21, 2022

    Leukemia, Lymphoma, Lymphoma, B-Cell Trial in New York (CAR T-Cell Infusion)

    Withdrawn
    • Leukemia
    • +2 more
    • CAR T-Cell Infusion
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Mar 4, 2022

    Hairy Cell Leukemia, Leukemia, Leukemia, Hairy Cell Trial in United States (Vemurafenib, Obinutuzumab)

    Active, not recruiting
    • Hairy Cell Leukemia
    • +2 more
    • New Haven, Connecticut
    • +8 more
    Feb 7, 2022

    Leukemia Trial in France, United States (BAY2402234)

    Terminated
    • Leukemia
    • Bronx, New York
    • +4 more
    Dec 20, 2021